The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Chicago
About this trial
This is a single-center prospective cohort study to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Eligibility criteria
Qualifiers
Controls: Adults above the age of 18.
Kidney stone patients: Adults above the age of 18.
History of majority (>50%) calcium oxalate kidney stones
Disqualifiers
Anyone with a history of calcium phosphate stones (>50% calcium phosphate), uric acid stones, struvite stones, recent urinary tract instrumentation (<30 days), or recurrent urinary tract infections.
Any individual who has had ACV outside of normal consumption in the prior month will be excluded.
Any individual who has a history of a negative reaction (increased acid reflux, allergy) to ACV will also be excluded.
Any individual with chronic kidney disease, underlying acid base disorder will also be excluded.
Trial design
Treatments tested in this trial
- Apple Cider Vinegar
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov